The Rise In China Deals: How International Biopharma Is Turning To China For Innovation

 
• By Joseph Haas, Mary Jo Laffler, and Nancy Pham
  
China Deals
Dealmaking between Chinese biopharmas and non-Asian firms is taking off (Dancing_Man/Shutterstock)
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Deal-Making

More from In Vivo